Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-22-004492

VP, Chief Accounting Officer acquired 6,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Guzzo Anthony J. VP, Chief Accounting Officer 2022-01-19 Grant or award +6,000 8,399 D
Derivatives
Guzzo Anthony J. VP, Chief Accounting Officer 2022-01-19 Grant or award · Stock Option (Right to Buy) +30,000 30,000 D
Loading xslF345X03/doc4.xml…